CD8A and infection: Resident memory CD8+ TC cells specific for SARS-CoV-2 persist in the nasal mucosa for at least two months after recovery from COVID-19 [68], and it seems likely that, analogous to influenza, they help resolve the infection in the URT and provide protective immunity in subsequent exposure to the virus.